Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.
Kim CG, Hong MH, Kim D, Lee BH, Kim H, Ock CY, Kelly G, Bang YJ, Kim G, Lee JE, Kim C, Kim SH, Hong HJ, Park YM, Sim NS, Park H, Park JW, Lee CG, Kim KH, Park G, Jung I, Han D, Kim JH, Cha J, Lee I, Kang M, Song H, Oum C, Kim S, Kim S, Lim Y, Kim-Schulze S, Merad M, Yoon SO, Kim HJ, Koh YW, Kim HR. Kim CG, et al. Among authors: kim h, kim g, kim hj, kim d, kim sh, kim schulze s, kim c, kim s, kim hr, kim kh, kim jh. Clin Cancer Res. 2024 May 15;30(10):2097-2110. doi: 10.1158/1078-0432.CCR-23-3249. Clin Cancer Res. 2024. PMID: 38457288 Clinical Trial.
Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer.
Youn JI, Park SM, Park S, Kim G, Lee HJ, Son J, Hong MH, Ghaderpour A, Baik B, Islam J, Choi JW, Lee EY, Kim HR, Seo SU, Paik S, Yoon HI, Jung I, Xin CF, Jin HT, Cho BC, Seong SY, Ha SJ, Kim HR. Youn JI, et al. Among authors: kim g, kim hr. Sci Rep. 2020 Jun 3;10(1):9050. doi: 10.1038/s41598-020-65666-x. Sci Rep. 2020. PMID: 32493990 Free PMC article.
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
Son J, Cho JW, Park HJ, Moon J, Park S, Lee H, Lee J, Kim G, Park SM, Lira SA, Mckenzie AN, Kim HY, Choi CY, Lim YT, Park SY, Kim HR, Park SH, Shin EC, Lee I, Ha SJ. Son J, et al. Among authors: kim hy, kim g, kim hr. Cancer Immunol Res. 2020 Nov;8(11):1393-1406. doi: 10.1158/2326-6066.CIR-19-0828. Epub 2020 Sep 2. Cancer Immunol Res. 2020. PMID: 32878747
Disproportional enrichment of FoxP3+ CD4+ regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma.
Park S, Kim CG, Kim D, Hong MH, Choi EC, Kim SH, Park YM, Kim J, Yoon SO, Kim G, Shin S, Kim K, Koh YW, Ha SJ, Kim HR. Park S, et al. Among authors: kim g, kim cg, kim d, kim sh, kim hr, kim j, kim k. Clin Transl Med. 2022 Mar;12(3):e753. doi: 10.1002/ctm2.753. Clin Transl Med. 2022. PMID: 35343075 Free PMC article. No abstract available.
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes.
Cha J, Kim DH, Kim G, Cho JW, Sung E, Baek S, Hong MH, Kim CG, Sim NS, Hong HJ, Lee JE, Hemberg M, Park S, Yoon SO, Ha SJ, Koh YW, Kim HR, Lee I. Cha J, et al. Among authors: kim g, kim dh, kim cg, kim hr. J Immunother Cancer. 2024 Jun 10;12(6):e008667. doi: 10.1136/jitc-2023-008667. J Immunother Cancer. 2024. PMID: 38857913 Free PMC article.
13,239 results
You have reached the last available page of results. Please see the User Guide for more information.